TRACON Pharmaceuticals Ownership 2024 | Who Owns TRACON Pharmaceuticals Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

9.35%

Insider Ownership

2.20%

Retail Ownership

88.44%

Institutional Holders

27.00

TRACON Pharmaceuticals Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
LPL FINANCIAL LLC	1.38%	0.00%	450,650	450,650	100.00%	193,689	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	1.26%	0.00%	413,909	-	-	176,000	Mar 31, 2024
SQUAREPOINT OPS LLC	1.19%	0.00%	388,985	-23,286	-5.65%	167,186	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.92%	0.00%	300,238	202,200	206.25%	129,000	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.88%	-	286,709	77,923	37.32%	123,228	Mar 31, 2024
VANGUARD GROUP INC	0.80%	-	262,772	-	-	112,939	Mar 31, 2024
BLACKROCK INC.	0.79%	-	260,084	-1,178	-0.45%	111,784	Mar 31, 2024
JANE STREET GROUP, LLC	0.56%	-	182,307	182,307	100.00%	78,356	Mar 31, 2024
UBS GROUP AG	0.28%	-	91,333	91,333	100.00%	39,273	Mar 31, 2024
JOHNSON & JOHNSON	0.26%	0.00%	84,003	-	-	36,104	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.24%	-	77,868	77,868	100.00%	33,468	Mar 31, 2024
STATE STREET CORP	0.23%	-	75,154	-	-	32,301	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	-	74,658	-116,795	-61.00%	32,088	Mar 31, 2024
CI PRIVATE WEALTH, LLC	0.18%	-	57,455	-	-	24,695	Mar 31, 2024
HRT FINANCIAL LP	0.17%	0.00%	54,364	54,364	100.00%	23,000	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	0.11%	-	34,822	34,822	100.00%	14,966	Mar 31, 2024
XTX TOPCO LTD	0.09%	0.00%	27,965	27,965	100.00%	12,019	Mar 31, 2024
ETF PORTFOLIO PARTNERS, INC.	0.08%	0.00%	24,641	24,641	100.00%	10,591	Mar 31, 2024
SPIDERROCK ADVISORS, LLC	0.07%	0.00%	22,983	22,983	100.00%	8,299	Mar 31, 2024
NORTHERN TRUST CORP	0.07%	-	21,691	-	-	9,323	Mar 31, 2024

TRACON Pharmaceuticals's largest institutional shareholder is LPL FINANCIAL LLC, holding 1.38% of the company's total share outstanding, currently valued at $193.69K. The top 10 institutional shareholders own together 8.31% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ETF PORTFOLIO PARTNERS, INC.	0.08%	0.00%	24,641	24,641	100.00%	10,591	Mar 31, 2024
XTX TOPCO LTD	0.09%	0.00%	27,965	27,965	100.00%	12,019	Mar 31, 2024
JOHNSON & JOHNSON	0.26%	0.00%	84,003	-	-	36,104	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	1.26%	0.00%	413,909	-	-	176,000	Mar 31, 2024
HOYLECOHEN, LLC	0.04%	0.00%	13,000	-	-	5,588	Mar 31, 2024
SQUAREPOINT OPS LLC	1.19%	0.00%	388,985	-23,286	-5.65%	167,186	Mar 31, 2024
GAME PLAN FINANCIAL ADVISORS, LLC	0.00%	0.00%	1,000	-	-	430	Mar 31, 2024
SPIDERROCK ADVISORS, LLC	0.07%	0.00%	22,983	22,983	100.00%	8,299	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.92%	0.00%	300,238	202,200	206.25%	129,000	Mar 31, 2024
HRT FINANCIAL LP	0.17%	0.00%	54,364	54,364	100.00%	23,000	Mar 31, 2024
JUMP FINANCIAL, LLC	0.03%	0.00%	10,500	10,500	100.00%	4,515	Mar 31, 2024
LPL FINANCIAL LLC	1.38%	0.00%	450,650	450,650	100.00%	193,689	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	7,579	-2,786	-26.88%	3,259	Mar 31, 2024
TRUVESTMENTS CAPITAL LLC	0.00%	0.00%	318	-	-	137,000	Mar 31, 2024
CI PRIVATE WEALTH, LLC	0.18%	-	57,455	-	-	24,695	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	0.11%	-	34,822	34,822	100.00%	14,966	Mar 31, 2024
JANE STREET GROUP, LLC	0.56%	-	182,307	182,307	100.00%	78,356	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	-	74,658	-116,795	-61.00%	32,088	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.88%	-	286,709	77,923	37.32%	123,228	Mar 31, 2024
MERCER GLOBAL ADVISORS INC /ADV	0.03%	-	10,000	10,000	100.00%	4,000	Mar 31, 2024

The largest TRACON Pharmaceuticals shareholder by % of total assets is ETF PORTFOLIO PARTNERS, INC.. The company owns 24.64K shares of TRACON Pharmaceuticals (TCON), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
LPL FINANCIAL LLC	1.38%	0.00%	450,650	450,650	100.00%	193,689	Mar 31, 2024
RENAISSANCE TECHNOLOGIES LLC	0.92%	0.00%	300,238	202,200	206.25%	129,000	Mar 31, 2024
JANE STREET GROUP, LLC	0.56%	-	182,307	182,307	100.00%	78,356	Mar 31, 2024
UBS GROUP AG	0.28%	-	91,333	91,333	100.00%	39,273	Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.88%	-	286,709	77,923	37.32%	123,228	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.24%	-	77,868	77,868	100.00%	33,468	Mar 31, 2024
HRT FINANCIAL LP	0.17%	0.00%	54,364	54,364	100.00%	23,000	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	0.11%	-	34,822	34,822	100.00%	14,966	Mar 31, 2024
XTX TOPCO LTD	0.09%	0.00%	27,965	27,965	100.00%	12,019	Mar 31, 2024
ETF PORTFOLIO PARTNERS, INC.	0.08%	0.00%	24,641	24,641	100.00%	10,591	Mar 31, 2024
SPIDERROCK ADVISORS, LLC	0.07%	0.00%	22,983	22,983	100.00%	8,299	Mar 31, 2024
JUMP FINANCIAL, LLC	0.03%	0.00%	10,500	10,500	100.00%	4,515	Mar 31, 2024
MERCER GLOBAL ADVISORS INC /ADV	0.03%	-	10,000	10,000	100.00%	4,000	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	207	3	1.47%	89,000	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	0.03%	-	10,259	-	-	4,409	Mar 31, 2024
STATE STREET CORP	0.23%	-	75,154	-	-	32,301	Mar 31, 2024
NORTHERN TRUST CORP	0.07%	-	21,691	-	-	9,323	Mar 31, 2024
VANGUARD GROUP INC	0.80%	-	262,772	-	-	112,939	Mar 31, 2024
CI PRIVATE WEALTH, LLC	0.18%	-	57,455	-	-	24,695	Mar 31, 2024
TRUVESTMENTS CAPITAL LLC	0.00%	0.00%	318	-	-	137,000	Mar 31, 2024

As of Mar 31 2024, TRACON Pharmaceuticals's largest institutional buyer is LPL FINANCIAL LLC. The company purchased 450.65K stocks of TCON, valued at $193.69K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
IKARIAN CAPITAL, LLC	-	-	-	-2,765,530	-100.00%	-	Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-258,844	-100.00%	-	Mar 31, 2024
MILLENNIUM MANAGEMENT LLC	0.23%	-	74,658	-116,795	-61.00%	32,088	Mar 31, 2024
SQUAREPOINT OPS LLC	1.19%	0.00%	388,985	-23,286	-5.65%	167,186	Mar 31, 2024
GTS SECURITIES LLC	-	-	-	-15,794	-100.00%	-	Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	0.00%	7,579	-2,786	-26.88%	3,259	Mar 31, 2024
BLACKROCK INC.	0.79%	-	260,084	-1,178	-0.45%	111,784	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	-	-800	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-201	-100.00%	-	Mar 31, 2024
JOHNSON & JOHNSON	0.26%	0.00%	84,003	-	-	36,104	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	1.26%	0.00%	413,909	-	-	176,000	Mar 31, 2024
HOYLECOHEN, LLC	0.04%	0.00%	13,000	-	-	5,588	Mar 31, 2024
GAME PLAN FINANCIAL ADVISORS, LLC	0.00%	0.00%	1,000	-	-	430	Mar 31, 2024
TRUVESTMENTS CAPITAL LLC	0.00%	0.00%	318	-	-	137,000	Mar 31, 2024
CI PRIVATE WEALTH, LLC	0.18%	-	57,455	-	-	24,695	Mar 31, 2024
VANGUARD GROUP INC	0.80%	-	262,772	-	-	112,939	Mar 31, 2024
NORTHERN TRUST CORP	0.07%	-	21,691	-	-	9,323	Mar 31, 2024
STATE STREET CORP	0.23%	-	75,154	-	-	32,301	Mar 31, 2024
BANK OF NEW YORK MELLON CORP	0.03%	-	10,259	-	-	4,409	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	207	3	1.47%	89,000	Mar 31, 2024

As of Mar 31 2024, TRACON Pharmaceuticals's biggest institutional seller is IKARIAN CAPITAL, LLC. The company sold -2.77M shares of TCON, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
LPL FINANCIAL LLC	1.38%	0.00%	450,650	450,650	100.00%	193,689	Mar 31, 2024
JANE STREET GROUP, LLC	0.56%	-	182,307	182,307	100.00%	78,356	Mar 31, 2024
UBS GROUP AG	0.28%	-	91,333	91,333	100.00%	39,273	Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP	0.24%	-	77,868	77,868	100.00%	33,468	Mar 31, 2024
HRT FINANCIAL LP	0.17%	0.00%	54,364	54,364	100.00%	23,000	Mar 31, 2024
TWO SIGMA INVESTMENTS, LP	0.11%	-	34,822	34,822	100.00%	14,966	Mar 31, 2024
XTX TOPCO LTD	0.09%	0.00%	27,965	27,965	100.00%	12,019	Mar 31, 2024
ETF PORTFOLIO PARTNERS, INC.	0.08%	0.00%	24,641	24,641	100.00%	10,591	Mar 31, 2024
SPIDERROCK ADVISORS, LLC	0.07%	0.00%	22,983	22,983	100.00%	8,299	Mar 31, 2024
JUMP FINANCIAL, LLC	0.03%	0.00%	10,500	10,500	100.00%	4,515	Mar 31, 2024
MERCER GLOBAL ADVISORS INC /ADV	0.03%	-	10,000	10,000	100.00%	4,000	Mar 31, 2024

TRACON Pharmaceuticals's largest new institutional shareholder by number of shares is LPL FINANCIAL LLC, purchased 450.65K shares, valued at $193.69K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
IKARIAN CAPITAL, LLC	-	-	-	-2,765,530	-100.00%	-	Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC	-	-	-	-258,844	-100.00%	-	Mar 31, 2024
GTS SECURITIES LLC	-	-	-	-15,794	-100.00%	-	Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD	-	-	-	-800	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	-	-	-	-201	-100.00%	-	Mar 31, 2024

TRACON Pharmaceuticals's largest sold out institutional shareholder by shares sold is IKARIAN CAPITAL, LLC, sold -2.77M shares, valued at -, as of undefined.

TRACON Pharmaceuticals Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.03%	13,800	-	-	Dec 31, 2023
BRIDGEWAY FUNDS INC	0.02%	60,000	-	-	Dec 29, 2023
BRIDGEWAY FUNDS INC	0.00%	6,000	-	-	Dec 29, 2023
VANGUARD INDEX FUNDS	0.00%	525,544	-98,854	-15.83%	Dec 31, 2023
T. Rowe Price Index Trust, Inc.	0.00%	17,400	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	200,699	-	-	Feb 29, 2024
AdvisorShares Trust	0.00%	1,772	-	-	Dec 29, 2023
SCHWAB CAPITAL TRUST	0.00%	22,638	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	11,168	-	-	Dec 31, 2023
Legg Mason Global Asset Management Trust	0.00%	42,900	-	-	Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	5,100	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	800	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,599	-	-	Dec 31, 2023

TRACON Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 13.80K shares, compromising 0.03% of its total assets.

TRACON Pharmaceuticals Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	27	22.73%
31 Dec, 23	22	22.22%
30 Sep, 23	18	-28.00%
30 Jun, 23	25	-21.88%
31 Mar, 23	32	-5.88%
31 Dec, 22	34	6.25%
30 Sep, 22	32	3.23%
30 Jun, 22	31	-18.42%
31 Mar, 22	38	2.70%
31 Dec, 21	37	-17.78%
30 Sep, 21	45	2.27%
30 Jun, 21	44	7.32%
31 Mar, 21	41	2.50%
31 Dec, 20	40	60.00%
30 Sep, 20	25	38.89%
30 Jun, 20	18	-
31 Mar, 20	18	38.46%
31 Dec, 19	13	-

As of 31 Mar 24, 27 institutions are holding TRACON Pharmaceuticals's shares, representing an increase of 22.73% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	3,063,147	-40.67%
31 Dec, 23	5,163,109	-44.46%
30 Sep, 23	9,296,999	-6.66%
30 Jun, 23	9,959,933	0.53%
31 Mar, 23	9,907,787	0.86%
31 Dec, 22	9,823,276	-0.27%
30 Sep, 22	9,849,440	-0.22%
30 Jun, 22	9,871,339	8.10%
31 Mar, 22	9,131,314	-0.10%
31 Dec, 21	9,140,084	-10.67%
30 Sep, 21	10,231,476	13.88%
30 Jun, 21	8,984,779	-1.78%
31 Mar, 21	9,147,249	8.22%
31 Dec, 20	8,452,461	47.67%
30 Sep, 20	5,723,970	268.36%
30 Jun, 20	1,553,917	22.72%
31 Mar, 20	1,266,241	62.85%
31 Dec, 19	777,529	-

TRACON Pharmaceuticals (TCON) has 3.06M shares outstanding as of 31 Mar 24, down -40.67% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	9.35%	4.74%
31 Dec, 23	14.04%	1.54%
30 Sep, 23	30.21%	1.71%
30 Jun, 23	42.02%	2.40%
31 Mar, 23	41.80%	1.90%
31 Dec, 22	46.96%	2.23%
30 Sep, 22	45.88%	1.93%
30 Jun, 22	48.70%	2.25%
31 Mar, 22	46.57%	1.66%
31 Dec, 21	52.98%	1.74%
30 Sep, 21	55.20%	1.64%
30 Jun, 21	57.98%	1.66%
31 Mar, 21	59.09%	1.98%
31 Dec, 20	54.60%	1.84%
30 Sep, 20	54.47%	9.20%
30 Jun, 20	24.33%	4.06%
31 Mar, 20	24.49%	4.04%
31 Dec, 19	24.61%	-

As of 31 Mar 24, TRACON Pharmaceuticals is held by 9.35% institutional shareholders, representing a 4.74% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	13	62.50%
31 Dec, 23	8	100.00%
30 Sep, 23	4	-33.33%
30 Jun, 23	6	-33.33%
31 Mar, 23	9	-25.00%
31 Dec, 22	12	140.00%
30 Sep, 22	5	-44.44%
30 Jun, 22	9	-40.00%
31 Mar, 22	15	36.36%
31 Dec, 21	11	-45.00%
30 Sep, 21	20	53.85%
30 Jun, 21	13	-43.48%
31 Mar, 21	23	-14.81%
31 Dec, 20	27	80.00%
30 Sep, 20	15	36.36%
30 Jun, 20	11	-
31 Mar, 20	11	-15.38%
31 Dec, 19	13	-

13 institutional shareholders have increased their position in TCON stock as of 31 Mar 24 compared to 8 in the previous quarter (a 62.50% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	4	-20.00%
31 Dec, 23	5	66.67%
30 Sep, 23	3	-25.00%
30 Jun, 23	4	-20.00%
31 Mar, 23	5	-28.57%
31 Dec, 22	7	-12.50%
30 Sep, 22	8	-
30 Jun, 22	8	-
31 Mar, 22	8	-
31 Dec, 21	8	-11.11%
30 Sep, 21	9	-30.77%
30 Jun, 21	13	62.50%
31 Mar, 21	8	100.00%
31 Dec, 20	4	-
30 Sep, 20	4	300.00%
30 Jun, 20	1	-66.67%
31 Mar, 20	3	-
31 Dec, 19	-	-

4 institutional shareholders have reduced their position in TCON stock as of 31 Mar 24 compared to 5 in the previous quarter (a -20.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	27	22.73%	3,063,147	-40.67%	9.35%	4.74%	13	62.50%	4	-20.00%
31 Dec, 23	22	22.22%	5,163,109	-44.46%	14.04%	1.54%	8	100.00%	5	66.67%
30 Sep, 23	18	-28.00%	9,296,999	-6.66%	30.21%	1.71%	4	-33.33%	3	-25.00%
30 Jun, 23	25	-21.88%	9,959,933	0.53%	42.02%	2.40%	6	-33.33%	4	-20.00%
31 Mar, 23	32	-5.88%	9,907,787	0.86%	41.80%	1.90%	9	-25.00%	5	-28.57%
31 Dec, 22	34	6.25%	9,823,276	-0.27%	46.96%	2.23%	12	140.00%	7	-12.50%
30 Sep, 22	32	3.23%	9,849,440	-0.22%	45.88%	1.93%	5	-44.44%	8	-
30 Jun, 22	31	-18.42%	9,871,339	8.10%	48.70%	2.25%	9	-40.00%	8	-
31 Mar, 22	38	2.70%	9,131,314	-0.10%	46.57%	1.66%	15	36.36%	8	-
31 Dec, 21	37	-17.78%	9,140,084	-10.67%	52.98%	1.74%	11	-45.00%	8	-11.11%
30 Sep, 21	45	2.27%	10,231,476	13.88%	55.20%	1.64%	20	53.85%	9	-30.77%
30 Jun, 21	44	7.32%	8,984,779	-1.78%	57.98%	1.66%	13	-43.48%	13	62.50%
31 Mar, 21	41	2.50%	9,147,249	8.22%	59.09%	1.98%	23	-14.81%	8	100.00%
31 Dec, 20	40	60.00%	8,452,461	47.67%	54.60%	1.84%	27	80.00%	4	-
30 Sep, 20	25	38.89%	5,723,970	268.36%	54.47%	9.20%	15	36.36%	4	300.00%
30 Jun, 20	18	-	1,553,917	22.72%	24.33%	4.06%	11	-	1	-66.67%
31 Mar, 20	18	38.46%	1,266,241	62.85%	24.49%	4.04%	11	-15.38%	3	-
31 Dec, 19	13	-	777,529	-	24.61%	-	13	-	-	-

TRACON Pharmaceuticals Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	47,000	$0.75	$35.25K	399,417
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	3,999	$0.66	$2.64K	352,417
Mar 13, 2023	Opaleye Management Inc.	10 percent owner	-	P-Purchase	Buy	174,508	$1.38	$240.82K	4,324,508
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	4,800	$1.52	$7.30K	344,918
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	200	$1.52	$304.00	340,118

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	47,000	$0.75	$35.25K	399,417
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	3,999	$0.66	$2.64K	352,417
Mar 13, 2023	Opaleye Management Inc.	10 percent owner	-	P-Purchase	Buy	174,508	$1.38	$240.82K	4,324,508
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	4,800	$1.52	$7.30K	344,918
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	200	$1.52	$304.00	340,118

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Feb 09, 2023	Adams Bonne J.	officer	Chief Operating Officer		Sell	-	-	-	4,267

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 13, 2024	Lazar David E.		-		Buy	-	-	-	-
Mar 13, 2024	Brown Scott B.	officer	CHIEF FINANCIAL OFFICER	A-Award	Buy	224,800	$0.39	$87.67K	224,800
Mar 13, 2024	Brown Scott B.	officer	CHIEF FINANCIAL OFFICER	A-Award	Buy	3,500	$0.14	$481.95	25,128
Mar 13, 2024	THEUER CHARLES	director, officer	PRESIDENT AND CEO	A-Award	Buy	518,300	$0.39	$202.14K	518,300
Mar 13, 2024	THEUER CHARLES	director, officer	PRESIDENT AND CEO	A-Award	Buy	3,500	$0.13	$466.55	406,417
Mar 13, 2024	THEUER CHARLES	director, officer	PRESIDENT AND CEO	A-Award	Buy	3,500	$0.14	$481.95	402,917
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	47,000	$0.75	$35.25K	399,417
Apr 28, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	3,999	$0.66	$2.64K	352,417
Apr 21, 2023	Johnson-Pratt Lisa	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	Lam Carol C.	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	PELLETIER SAUNDRA L	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	MATTINGLY MARTIN A	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	WORLAND STEPHEN T	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	LARUE WILLIAM R	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Apr 21, 2023	Twiford J Rainer	director	-	A-Award	Buy	18,000	$1.82	$32.76K	18,000
Mar 13, 2023	Opaleye Management Inc.	10 percent owner	-	P-Purchase	Buy	174,508	$1.38	$240.82K	4,324,508
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	4,800	$1.52	$7.30K	344,918
Mar 02, 2023	THEUER CHARLES	director, officer	President and CEO	P-Purchase	Buy	200	$1.52	$304.00	340,118
Feb 09, 2023	Adams Bonne J.	officer	Chief Operating Officer	A-Award	Buy	99,000	$1.70	$168.30K	99,000
Feb 09, 2023	Adams Bonne J.	officer	Chief Operating Officer		Sell	-	-	-	4,267

The last insider sell of TRACON Pharmaceuticals's stock was made by Adams Bonne J. on Feb 09 2023, selling - shares at - per share (valued at -). The last insider buy of TCON was made by THEUER CHARLES on Apr 28 2023, buying 47,000 shares at $0.75 per share (worth $35.25K).

TRACON Pharmaceuticals Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	2	-	-
Q4 2023	1	-	-
Q2 2023	11	-	-
Q1 2023	7	10	70.00%
Q4 2022	12	3	400.00%
Q3 2022	13	-	-
Q2 2022	35	-	-
Q1 2022	15	-	-
Q4 2021	25	-	-
Q3 2021	4	-	-
Q2 2021	6	-	-
Q1 2021	6	-	-
Q4 2020	11	-	-
Q3 2020	39	-	-
Q2 2020	11	-	-
Q1 2020	11	2	550.00%
Q4 2019	-	2	-
Q3 2019	1	5	20.00%
Q2 2019	5	-	-
Q1 2019	-	1	-

2 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by TRACON Pharmaceuticals's insiders, as of Q1 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q1 2024	-	-	-
Q4 2023	-	-	-
Q2 2023	2	-	-
Q1 2023	4	-	-
Q4 2022	11	2	550.00%
Q3 2022	13	-	-
Q2 2022	24	-	-
Q1 2022	12	-	-
Q4 2021	24	-	-
Q3 2021	4	-	-
Q2 2021	-	-	-
Q1 2021	2	-	-
Q4 2020	11	-	-
Q3 2020	39	-	-
Q2 2020	5	-	-
Q1 2020	7	-	-
Q4 2019	-	2	-
Q3 2019	1	-	-
Q2 2019	-	-	-
Q1 2019	-	-	-

As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of TRACON Pharmaceuticals's stocks.

TRACON Pharmaceuticals Peer Ownership

Ticker	Company
ANTX	AN2 Therapeutics, Inc.
ANEB	Anebulo Pharmaceuticals, Inc.
RZLT	Rezolute, Inc.
PMVP	PMV Pharmaceuticals, Inc.
TPST	Tempest Therapeutics, Inc.
SIOX	Sio Gene Therapies Inc.
HSTO	Histogen Inc.
ENOB	Renovaro Biosciences Inc.
XOMA	XOMA Corporation
IKT	Inhibikase Therapeutics, Inc.
ACXP	Acurx Pharmaceuticals, Inc.
VINC	Vincerx Pharma, Inc.
CADL	Candel Therapeutics, Inc.
MNPR	Monopar Therapeutics Inc.
LRMR	Larimar Therapeutics, Inc.
CYCN	Cyclerion Therapeutics, Inc.
ACHL	Achilles Therapeutics plc
ENTX	Entera Bio Ltd.
ADXN	Addex Therapeutics Ltd
KRON	Kronos Bio, Inc.

TCON Ownership FAQ

Who Owns TRACON Pharmaceuticals?

TRACON Pharmaceuticals is owned by institutional shareholders (9.35%), insiders (2.20%), and public (88.44%). The largest institutional shareholder of TRACON Pharmaceuticals is LPL FINANCIAL LLC (1.38% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.03% of total shares).

Who are the major institutional shareholders of TRACON Pharmaceuticals?

TRACON Pharmaceuticals's major institutional shareholders are LPL FINANCIAL LLC, ACADIAN ASSET MANAGEMENT LLC, SQUAREPOINT OPS LLC, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC. The top five shareholders own together 5.62% of the company's share outstanding.

How many TRACON Pharmaceuticals shareholders are there?

As of Mar 2024, there are 27 institutional shareholders of TRACON Pharmaceuticals.

What percentage of TRACON Pharmaceuticals is owned by LPL FINANCIAL LLC?

LPL FINANCIAL LLC owns 450.65K shares of TRACON Pharmaceuticals, representing 1.38% of the company's total shares outstanding, valued at $193.69K (as of Mar 2024).

What percentage of TRACON Pharmaceuticals is owned by ACADIAN ASSET MANAGEMENT LLC?

As of Mar 2024, ACADIAN ASSET MANAGEMENT LLC holds 413.91K shares of TRACON Pharmaceuticals (TCON), compromising 1.26% of the company, valued at $176K.

What percentage of TRACON Pharmaceuticals is owned by SQUAREPOINT OPS LLC?

SQUAREPOINT OPS LLC is the third largest holder of TRACON Pharmaceuticals. The company owns 388.98K of the company's shares outstanding (worth $167.19K).